MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fpubh.2025.1532604

Медицинская библиотека · Frontiers in public health · 2025

Health economic evaluation of newborn hepatitis B immunization prevention strategies in Ningbo: a Markov modeling study.

Feng Wei, Li Zhengxiong, Fan Mingkuan, Yang Sijia, Shao Yuqi, Liu Kui, Huang Shuaishuai, Fu Sanjun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Hepatitis B virus (HBV) infection poses a significant public health challenge in China. The Prevention of mother-to-child Transmission (PMTCT) strategy of combining universal hepatitis B vaccination with hepatitis B immunoglobulin (HBIG) for newborns is crucial in preventing widespread infection. In this study, we conduct health economic evaluation of three strategies: PMTCT, universal vaccination, and non-vaccination for newborns in Ningbo, China.

METHODS

This study developed a decision-Markov model and simulated a cohort of 100,000 newborns to assess the cost-effectiveness and cost-benefit of three strategies from a healthcare system perspective. The primary outputs included total costs, life-years (LYs), quality-adjusted life-years (QALYs), incremental cost-effectiveness ratios (ICERs), benefit-cost ratios (BCRs). One-way and probabilistic sensitivity analyses (PSA) were performed to verify the robustness of the model.

RESULTS

Among the three strategies, the PMTCT results in the least disease burden and mortality related to hepatitis B. In comparison to a cohort of 100,000 unvaccinated infants, the PMTCT is expected to prevent 6,029 cases of acute symptomatic infections, 27,348 HBV carriers, 4,170 chronic infections, 3,597 cases of cirrhosis, 2,911 cases of hepatocellular carcinoma (HCC), and 3,930 HBV-related deaths. The ICERs for PMTCT and universal vaccination were - 56,371.77 yuan/QALY and - 56,654.77 yuan/QALY, respectively. The BCRs for PMTCT and universal vaccination were 19.13 and 15.95, respectively, when compared to no vaccination. The PSA revealed that all ICER scatter points are situated within the fourth quadrant, and the probability of PMTCT being cost-effective exceeds 90%.

CONCLUSION

Implementing universal hepatitis B vaccination with HBIG for newborns in Ningbo demonstrated high cost-effectiveness, making the continuation of the PMTCT strategy highly recommended.

Для цитирования: Feng Wei, Li Zhengxiong, Fan Mingkuan, Yang Sijia, Shao Yuqi, Liu Kui, Huang Shuaishuai, Fu Sanjun. Health economic evaluation of newborn hepatitis B immunization prevention strategies in Ningbo: a Markov modeling study.. Frontiers in public health. 2025. DOI: 10.3389/fpubh.2025.1532604.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.